Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational Screening of Natural Compounds for Identification of Potential Anti-Cancer Agents Targeting MCM7 Protein. | Molecules | 2021 | 34641424 | PubTator, text mining | PubMed |
| Macrophages, Metabolites, and Nucleosomes: Chromatin at the Intersection between Aging and Inflammation. | Int J Mol Sci | 2021 | 34638614 | PubTator, text mining | PubMed |
| Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma. | BMC Cancer | 2021 | 34615513 | PubTator, text mining | PubMed |
| Culturable Fungi from Urban Soils in China I: Description of 10 New Taxa. | Microbiol Spectr | 2021 | 34612666 | PubTator, text mining | PubMed |
| RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2. | Oncogene | 2021 | 34611311 | PubTator, text mining | PubMed |
| Immunohistochemical evaluation of D2-40, Galectin-3, Maspin and MCM7 expression in palate squamous cell carcinomas. | Rom J Morphol Embryol | 2021 | 34609416 | PubTator, text mining | PubMed |
| SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition. | Nat Commun | 2021 | 34599168 | PubTator, text mining | PubMed |
| Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells. | Front Cell Dev Biol | 2021 | 34595169 | PubTator, text mining | PubMed |
| Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance. | FEBS Open Bio | 2021 | 34586751 | PubTator, text mining | PubMed |
| Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma. | J Transl Med | 2021 | 34579737 | PubTator, text mining | PubMed |
| Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database. | Genes (Basel) | 2021 | 34573332 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Reveals Common and Specific Relationships between Intragenic miRNAs and Their Host Genes. | Biomedicines | 2021 | 34572448 | PubTator, text mining | PubMed |
| Integrative genomics analysis of nasal intestinal-type adenocarcinomas demonstrates the major role of CACNA1C and paves the way for a simple diagnostic tool in male woodworkers. | Clin Epigenetics | 2021 | 34563241 | PubTator, text mining | PubMed |
| Expression and prognosis of CDC45 in cervical cancer based on the GEO database. | PeerJ | 2021 | 34557356 | PubTator, text mining | PubMed |
| Disruption of origin chromatin structure by helicase activation in the absence of DNA replication. | Genes Dev | 2021 | 34556529 | PubTator, text mining | PubMed |
| Systems approaches identify the consequences of monosomy in somatic human cells. | Nat Commun | 2021 | 34552071 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| Efficiency and equity in origin licensing to ensure complete DNA replication. | Biochem Soc Trans | 2021 | 34545932 | PubTator, text mining | PubMed |
| Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma. | Cancer Cell Int | 2021 | 34544452 | PubTator, text mining | PubMed |
| Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z. | J Biol Chem | 2021 | 34537242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=33